Brookstone Capital Management

Position in ELAN — Elanco Animal Health Inc

CIK 1599584 WHEATON, IL

Position in ELAN

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$785,895

+$121,185 QoQ

Shares Held

31,934

+8.7% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#246

of 518 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Brookstone Capital Management holds $6,325,490 across 5 Drug Manufacturers - Specialty & Generic names. ELAN ranks #4 (12.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	5,944	$3,220,637
2	HROW	Harrow, Inc.	31,153	$1,323,067
3	NBIX	Neurocrine Biosciences Inc	4,681	$788,935
4	ELAN	Elanco Animal Health Inc This page	31,934	$785,895
5	ZTS	Zoetis Inc.	2,880	$206,956

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$785,895	31,934	+8.7%	Shares	Sole	2026-07-15
2025-12-31	$664,710	29,373	—	Shares	Sole	2026-01-15
No filing history on record for this holder in this stock.